Jasmine G Hughes, Francesca M Cozzi, Veronica Phillips, Stephen J Price
{"title":"Shared decision-making interventions in neuro-oncology practice: a systematic review.","authors":"Jasmine G Hughes, Francesca M Cozzi, Veronica Phillips, Stephen J Price","doi":"10.1007/s11060-025-05141-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Shared decision-making (SDM) has been shown to be beneficial to patients and improve health outcomes. While more research is being conducted on the topic of SDM, the incorporation of interventions to facilitate or improve SDM in neuro-oncology has not been widely studied. This study aimed to systematically review the types and impact of SDM interventions used in neuro-oncology.</p><p><strong>Methods: </strong>Systematic searches were conducted in Medline, Embase, Global Health, Cinahl, Web of Science, and Scopus from inception to May 2024. Full-text, peer-reviewed articles were evaluated based on inclusion criteria. Data extracted from articles included the author, year, location, type of intervention, and variable outcomes.</p><p><strong>Results: </strong>The searches resulted in 4674 original articles. Four studies with a total of 172 patients diagnosed with anaplastic oligodendroglioma, anaplastic astrocytoma, high-grade glioma (HGG), low-grade glioma (LGG), glioblastoma, and brain metastases met the inclusion criteria. Types of SDM interventions included SDM training for health care workers, decision grids, three-dimensional (3D) printed models of brain tumors, goals of care videos, and an online tool providing information on disease progression. Overall impact of SDM interventions resulted in improvement in patients' understanding of their medical condition, treatment options, and satisfaction with the SDM process.</p><p><strong>Conclusion: </strong>SDM can be improved through the use of interventions and aids and can have a positive impact on brain tumor patients. However, there is a significant gap within neuro-oncology literature on SDM interventions. Therefore, to understand how to best improve SDM from the perspective of patients, there is a pressing need for more research on SDM interventions in neuro-oncology.</p>","PeriodicalId":16425,"journal":{"name":"Journal of Neuro-Oncology","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neuro-Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11060-025-05141-7","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Shared decision-making (SDM) has been shown to be beneficial to patients and improve health outcomes. While more research is being conducted on the topic of SDM, the incorporation of interventions to facilitate or improve SDM in neuro-oncology has not been widely studied. This study aimed to systematically review the types and impact of SDM interventions used in neuro-oncology.
Methods: Systematic searches were conducted in Medline, Embase, Global Health, Cinahl, Web of Science, and Scopus from inception to May 2024. Full-text, peer-reviewed articles were evaluated based on inclusion criteria. Data extracted from articles included the author, year, location, type of intervention, and variable outcomes.
Results: The searches resulted in 4674 original articles. Four studies with a total of 172 patients diagnosed with anaplastic oligodendroglioma, anaplastic astrocytoma, high-grade glioma (HGG), low-grade glioma (LGG), glioblastoma, and brain metastases met the inclusion criteria. Types of SDM interventions included SDM training for health care workers, decision grids, three-dimensional (3D) printed models of brain tumors, goals of care videos, and an online tool providing information on disease progression. Overall impact of SDM interventions resulted in improvement in patients' understanding of their medical condition, treatment options, and satisfaction with the SDM process.
Conclusion: SDM can be improved through the use of interventions and aids and can have a positive impact on brain tumor patients. However, there is a significant gap within neuro-oncology literature on SDM interventions. Therefore, to understand how to best improve SDM from the perspective of patients, there is a pressing need for more research on SDM interventions in neuro-oncology.
背景:共同决策(SDM)已被证明对患者有益并改善健康结果。虽然关于SDM的研究越来越多,但在神经肿瘤学中纳入干预措施以促进或改善SDM尚未得到广泛研究。本研究旨在系统回顾SDM干预在神经肿瘤学中的类型和影响。方法:系统检索Medline、Embase、Global Health、Cinahl、Web of Science、Scopus等自成立至2024年5月的文献。全文、同行评议的文章根据纳入标准进行评估。从文章中提取的数据包括作者、年份、地点、干预类型和可变结果。结果:检索结果为4674篇原创文章。4项研究共172例诊断为间变性少突胶质细胞瘤、间变性星形细胞瘤、高级别胶质瘤(HGG)、低级别胶质瘤(LGG)、胶质母细胞瘤和脑转移的患者符合纳入标准。SDM干预措施的类型包括针对卫生保健工作者的SDM培训、决策网格、脑肿瘤的三维(3D)打印模型、护理目标视频以及提供疾病进展信息的在线工具。SDM干预措施的总体影响是改善患者对其医疗状况、治疗选择和对SDM过程的满意度。结论:SDM可通过干预和辅助手段得到改善,对脑肿瘤患者可产生积极影响。然而,在SDM干预的神经肿瘤学文献中存在显著差距。因此,为了从患者的角度了解如何最好地提高SDM,迫切需要更多的SDM干预神经肿瘤的研究。
期刊介绍:
The Journal of Neuro-Oncology is a multi-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neurodiagnosticians, and laboratory-based oncologists conducting relevant research. The Journal of Neuro-Oncology does not seek to isolate the field, but rather to focus the efforts of many disciplines in one publication through a format which pulls together these diverse interests. More than any other field of oncology, cancer of the central nervous system requires multi-disciplinary approaches. To alleviate having to scan dozens of journals of cell biology, pathology, laboratory and clinical endeavours, JNO is a periodical in which current, high-quality, relevant research in all aspects of neuro-oncology may be found.